alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### I N THE UNI TED STATES COURT OF APPEALS FOR THE FI F TH CI RCUI T

No. 13-40088 Conference Calendar
UNITED STATES OF AMERICA, Plaintiff-Appellee

v. JOSE ALFREDO GARCIA, Defendant-Appellant

A ppeal from the United States District Court for the Southern District of Texas USDC No. 5:12-CR-682-1
Before HIGGINBOTHAM, SMITH, and GRAVES, Circuit Judges. PER CURIAM: * The attorney appointed to represent Jose A l f r e d o Garcia has moved for leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U.S. 738 ( 1967), and United State s v . Flores , 632 F.3d 2 29 ( 5th Cir. 2011). Garcia has not filed a timely response. W e have reviewed counsel’s b rief and the relevant portio n s o f the r ecord reflected therein. We concur with c ounsel’s assessment that the appeal presents no nonfrivolous issue f or appellate review. Accordingly, counsel’s motion fo r l e a ve to withdraw i s GRANTED, counsel is U n i t e d S t a te s C o u r t o f A p p e al s

F i f t h C i rc u i t 

### F I L E D Aug ust 20, 2013 Ly l e W . Cay ce Clerk

* Purs uant to 5 T H C I R
. R

. 47. 5, the court has d eterm ined that this op inion should not be p ublis hed and is not p reced ent excep t und er the lim ited circum s tances s et forth in 5 T H C I R
. R. 47. 5. 4. Case: 13-40088 Document: 00512347851 Page: 1 Date Filed: 08/20/2013No. 13-40088

excused from further r esponsibilities herein, and the APPEAL IS D ISMISSED. See 5 T H C I R
. R

. 42.2. All outstanding motions are DENIED.

2 Case: 13-40088 Document: 00512347851 Page: 2 Date Filed: 08/20/2013
!!"##$%$&'( "!(!)*+,-.

/*#$01/223+34+,-. 56"(5%(7%86 9:;:7<(56%65:7/%:(7(9/7 /=%:(756</5:7</"/%67%(5 %5/6/5> ?@ABCDEFG@H	IFJKLMNOAPQG@R
BSMNOAPTUBVGS	K	S	WUGR
FX	RJKGJGHBVSJGHJFB@KGXW		@ YFE	RF@JK	NOZFXJSFHJABVSJ B@JK	YBEEBIF@[ \SGR	CGS]XBS \^GJ	@JX_\JK	DGJ	@JGHJFB@F@
BE
	XLMNOAPQ ZA`ab Zac?daZ NOZ?O?AAN ^d?b?cc ZacabZb ^ab Zae`b Zac^ab Zae` fdZac^abZae` LgM ?@JK	GWB
	h	@JFJE	RHGX	iJK	YBEEBIF@[DGJ	@JX
JSGR	CGS]XKG
	W		@F@HEVR	R Za?bAdNZaZ ?bAdNZaZjk \C	@RC	@J \@XI	S \ASBXXjFEE \ JK	S^E	GRF@[

^ab Zae`b Zac^ab Zae` fdZac^abZae` LgM ?@JK	GWB
	h	@JFJE	RHGX	iJK	YBEEBIF@[R	HFXFB@KGXW		@S	@R	S	RBSlVR[	C	@JFXXV	R ZaA?O?b
mNZnaeab Ada` jkZa^NkAda` Za =o+p ####0&qo=o3p #&###0&qo =o2p ##r$s&#$$#r#tqu0&qo=o,p=qo

February 28, 2023

8,019,091 9/13/2011 Jawbone Innovations, LLC

Jawbone Innovations, LLC

Jawbone Innovations, LLC

Jawbone Innovations, LLC

Jawbone Innovations, LLC

7,246,058 7/17/2007

10,779,080 9/15/2020

11,122357 9/14/2021

8,467,543 6/18/2013

PAGE 1 of 2

x

for the Eastern District of Texas, Marshall Division

for the Eastern District of Texas, Marshall Division

Jawbone Innovations, LLC Guangdong OPPO Mobile Telecommunications

Corp., Ltd., d/b/a OPPO

2:23-cv-00079

Case 2:23-cv-00079 Document 2 Filed 02/28/23 Page 1 of 2 PageID #: 60
	

    !!"##$%$&'( "!(!)*+,-.

/*#$01/223+34+,-. 56"(5%(7%86 9:;:7<(56%65:7/%:(7(9/7 /=%:(756</5:7</"/%67%(5 %5/6/5> ?@ABCDEFG@H	IFJKLMNOAPQG@R
BSMNOAPTUBVGS	K	S	WUGR
FX	RJKGJGHBVSJGHJFB@KGXW		@ YFE	RF@JK	NOZFXJSFHJABVSJ B@JK	YBEEBIF@[ \SGR	CGS]XBS \^GJ	@JX_\JK	DGJ	@JGHJFB@F@
BE
	XLMNOAPQ ZA`ab Zac?daZ NOZ?O?AAN ^d?b?cc ZacabZb ^ab Zae`b Zac^ab Zae` fdZac^abZae` LgM ?@JK	GWB
	h	@JFJE	RHGX	iJK	YBEEBIF@[DGJ	@JX
JSGR	CGS]XKG
	W		@F@HEVR	R Za?bAdNZaZ ?bAdNZaZjk \C	@RC	@J \@XI	S \ASBXXjFEE \ JK	S^E	GRF@[

^ab Zae`b Zac^ab Zae` fdZac^abZae` LgM ?@JK	GWB
	h	@JFJE	RHGX	iJK	YBEEBIF@[R	HFXFB@KGXW		@S	@R	S	RBSlVR[	C	@JFXXV	R ZaA?O?b
mNZnaeab Ada` jkZa^NkAda` Za =o+p ####0&qo=o3p #&###0&qo =o2p ##r$s&#$$#r#tqu0&qo=o,p=qo

February 28, 2023

8,503,691 8/6/2013 Jawbone Innovations, LLC

Jawbone Innovations, LLC

Jawbone Innovations, LLC

8,321,213 11/27/2012

8,326,611 12/4/2012

PAGE 2 of 2

for the Eastern District of Texas, Marshall Division

for the Eastern District of Texas, Marshall Division

x

Jawbone Innovations, LLC Guangdong OPPO Mobile Telecommunications

Corp., Ltd., d/b/a OPPO

2:23-cv-00079

Case 2:23-cv-00079 Document 2 Filed 02/28/23 Page 2 of 2 PageID #: 61
IB

Union Calendar No. 117

106TH CONGRESS

1ST SESSION H. R. 2014

[Report No. 106–203]

To prohibit a State from imposing a discriminatory commuter tax on

nonresidents.

IN THE HOUSE OF REPRESENTATIVES

JUNE 7, 1999

Mr. FRANKS of New Jersey (for himself, Mr. FRELINGHUYSEN, and Mrs.

ROUKEMA) introduced the following bill; which was referred to the Committee on the Judiciary

JUNE 25, 1999

Additional sponsors: Mr. PALLONE, Mr. ROTHMAN, Mr. PASCRELL, Mr.

MALONEY of Connecticut, and Mr. SHAYS

JUNE 25, 1999

Committed to the Committee of the Whole House on the State of the Union

and ordered to be printed

A BILL

To prohibit a State from imposing a discriminatory

commuter tax on nonresidents.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•HR 2014 RH

1 SECTION 1. PROHIBITION ON IMPOSING DISCRIMINATORY

2 COMMUTER TAX ON NONRESIDENTS.

3 (a) PROHIBITION.—A State may not impose a tax on

4 the income earned in the State by nonresidents unless the

5 tax is of substantial equality of treatment for the citizens

6 of the State and the nonresidents so commuting.

7 (b) STATE.—For purposes of subsection (a), the term

8 ‘‘State’’ includes the District of Columbia and any political

9 subdivision of a State.

Union Calendar No. 117

106TH CONGRESS

1ST SESSION H. R. 2014

[Report No. 106–203]

A BILL

To prohibit a State from imposing a discriminatory

commuter tax on nonresidents.

JUNE 25, 1999

Committed to the Committee of the Whole House on the

State of the Union and ordered to be printed
**Statement Regarding Computation of Per Share Earnings**



|                                                                                                                                                  | Year Ended June 30,   
|------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------
|                                                                                                                                                  | 2001                  
|                                                                                                                                                  | (Dollars in thousands)
|Basic
  Average shares outstanding                                                                                                                | 1,229,652             
|Net income                                                                                                                                        | $1,548,602            
|Basic earnings per share                                                                                                                          | $         1.26        
|                                                                                                                                                  |                       
|Diluted
  Average shares outstanding                                                                                                              | 1,229,652             
|                                                                                                                                                  |                       
|Net effect of dilutive stock options - based on the
treasury stock method using the period end market
price, if greater than average market price | 10,507                
|                                                                                                                                                  |                       
|Total                                                                                                                                             | 1,240,159             
|Net income                                                                                                                                        | $1,548,602            
|Diluted earnings per share                                                                                                                        | $         1.25
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                       0
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                       1000
<COMMON>                                         74150
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
[Federal Register Volume 87, Number 97 (Thursday, May 19, 2022)]
[Notices]
[Page 30448]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10746]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-19-2022]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico, Notification 
of Proposed Production Activity, AbbVie Ltd., (Pharmaceutical 
Products), Barceloneta, Puerto Rico

    AbbVie Ltd., submitted a notification of proposed production 
activity to the FTZ Board (the Board) for its facility in Barceloneta, 
Puerto Rico within Subzone 7I. The notification conforming to the 
requirements of the Board's regulations (15 CFR 400.22) was received on 
May 13, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material and specific finished 
product described in the submitted notification (summarized below) and 
subsequently authorized by the Board. The benefits that may stem from 
conducting production activity under FTZ procedures are explained in 
the background section of the Board's website--accessible via 
www.trade.gov/ftz. The proposed finished product and material would be 
added to the production authority that the Board previously approved 
for the operation, as reflected on the Board's website.
    The proposed finished product is venetoclax film coated tablets 
(duty-free).
    The proposed foreign-status material is venetoclax active 
pharmaceutical ingredient (duty rate 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
<a href="/cdn-cgi/l/email-protection#89effdf3c9fdfbe8edeca7eee6ff"><span class="__cf_email__" data-cfemail="127466685266607376773c757d64">[email protected]</span></a>. The closing period for their receipt is June 28, 2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Christopher Wedderburn at 
<a href="/cdn-cgi/l/email-protection#d192b9a3b8a2ff86b4b5b5b4a3b3a4a3bf91a5a3b0b5b4ffb6bea7"><span class="__cf_email__" data-cfemail="4003283229336e1725242425322235322e0034322124256e272f36">[email protected]</span></a>.

    Dated: May 13, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022-10746 Filed 5-18-22; 8:45 am]
BILLING CODE 3510-DS-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit31.2**

**CERTIFICATION**

I,Thomas F. Wolfe, Senior Vice President and Chief Financial Officer of AffinityGroup, Inc., certify that:

1.             I have reviewed this quarterlyreport on Form 10-Q of Affinity Group, Inc.;

2.             Based on my knowledge, this reportdoes not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading withrespect to the period covered by this report;

3.             Based on my knowledge, thefinancial statements, and other financial information included in thisquarterly report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, and for,the periods presented in this report;

4.             Theregistrant’s other certifying officer(s) and I are responsible for establishingand maintaining disclosure controls and procedures, (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the registrant, and we have:

(a)     Designedsuch disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries,is made known to us by others within those entities, particularly during theperiod in which this report is being prepared;

(b)     Evaluatedthe effectiveness of the registrant’s disclosure controls and procedures andpresented in this quarterly report our conclusions about the effectiveness ofthe disclosure controls and procedures, as of the end of the period covered bythis report based on such evaluation; and

(c)     Disclosedin this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

5.             Theregistrant’s other certifying officer(s) and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of registrant’s board ofdirectors (or persons performing the equivalent function):

(a)     Allsignificant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize andreport financial information; and

(b)     Anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal controls over financialreporting.
| Date: August 14, 2006 |   | /s/ Thomas F. Wolfe        |   |
|-----------------------|--------|----------------------------|--------|
|                  |   | Thomas F. Wolfe            |
|                  |   | Senior Vice  President and |
|                  |   | Chief Financial  Officer   |

 

----
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Timeline, Inc. (the "Company")
on Form 10-QSB for the period ended September 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Charles
R. Osenbaugh, President and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


         /s/ Charles R. Osenbaugh                    Date: November 13, 2003
         ------------------------                          -------------------
         Charles R. Osenbaugh,
         President and Chief Financial Officer


A signed original of this written statement required by Section 906 has been
provided to Timeline, Inc. and will be retained by Timeline, Inc. and furnished
to the Securities and Exchange Commission or its staff upon request.
Exhibit 31.1
                                CEO Certification

I, Bradley T. MacDonald, the registrant, Chairman of the Board and Chief
Executive Officer certify that:

1.    I have reviewed this quarterly report on Form 10-Q of Medifast, Inc.;

2.    Based on my knowledge, this 10-Q does not contain any untrue statement of
      a material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this
      report;

3.    Based on my knowledge, the financial statements, and other financial
      information included in this report, fairly present in all material
      respects the financial condition, results of operations and cash flows of
      the registrant as of, and for the periods presented in this report;

4.    I am responsible for establishing and maintaining disclosure controls and
      procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
      registrant and have:

      a.    Designed such disclosure controls and procedures to ensure that
            material information relating to the registrant, including its
            consolidated subsidiaries, is made known to us by others within
            those entities, particularly during the period by which this report
            is being prepared;

      b.    Evaluated the effectiveness of the registrant's disclosure controls
            and procedures and presented in this report our conclusions about
            the effectiveness of the disclosure controls and procedures, as of
            the end of the period covered by this report based on such
            evaluation; and

      c.    Disclosed in this report any change in the registrant's internal
            control over financial reporting that occurred during the
            registrant's most recent fiscal quarter (the registrant's fourth
            quarter in the case of an annual report) that has materially
            affected, or is reasonably likely to materially affect, the
            registrant's internal control over financial reporting; and

5.    I have disclosed, based on our most recent evaluation, to the registrant's
      auditors and the audit committee of registrant's board of directors:

      a.    All significant deficiencies in the design or operation of internal
            controls which could adversely affect the registrant's ability to
            record, process, summarize and report financial data and have
            identified for the registrant's auditors any material weaknesses in
            internal controls; and

      b.    Any fraud, whether or not material, that involves management or
            other employees who have a significant role in the registrant's
            internal control over financial reporting.

August 9, 2005

Bradley T. MacDonald
Chairman of the Board & Chief Executive Officer
Exhibit 32.1




                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER

   Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)


         The  undersigned   executive   officer  of  WVS  Financial  Corp.  (the
"Registrant")  hereby certifies that the  Registrant's  Quarterly Report on Form
10-Q  for the  three  months  ended  March  31,  2006  fully  complies  with the
requirements  of Section 13(a) of the  Securities  Exchange Act of 1934 and that
the information contained therein fairly presents, in all material respects, the
financial condition and results of operations of the Registrant.




                                                    /s/ David J. Bursic
                                                    ----------------------------
                                                    David J. Bursic
                                                    President and
                                                    Chief Executive Officer


Date:  May 15, 2006


Note: A signed original of this written statement required by Section 906 of the
Sarbanes-Oxley Act has been provided to WVS Financial Corp. and will be retained
by WVS Financial  Corp. and furnished to the Securities and Exchange  Commission
or its staff upon request.


                                      E-3
TVEYES, INC., petitioner, v. FOX NEWS NETWORK, LLC.

No. 18-321.

Supreme Court of the United States

Dec. 3, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.